Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolism of Methylphenidate and Enalapril Based on CES1 Genotype

NCT02135263 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.

NCT NCT02135263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02135263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolism of Methylphenidate and Enalapril Based on CES1 Genotype
Lead sponsor
Bispebjerg Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2012
Completion date
May 31, 2014
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carboxylesterase 1 (ces1) genotype, ces1 activity